Amgen, Inc. (AMGN)
313.85
-7.38
(-2.30%)
USD |
NASDAQ |
Dec 09, 16:00
314.25
+0.40
(+0.13%)
After-Hours: 20:00
Amgen Research and Development Expense (TTM): 6.828B for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Biogen, Inc. | 1.524B |
| Gilead Sciences, Inc. | 5.734B |
| Johnson & Johnson | 15.77B |
| Eli Lilly & Co. | 12.56B |
| Regeneron Pharmaceuticals, Inc. | 5.097B |